Alk-Abello A/S (STU:4AJ0) FCF Margin % : 16.58% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Alk-Abello A/S FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alk-Abello A/S's Free Cash Flow for the three months ended in Mar. 2024 was €30.0 Mil. Alk-Abello A/S's Revenue for the three months ended in Mar. 2024 was €181.2 Mil. Therefore, Alk-Abello A/S's FCF Margin % for the quarter that ended in Mar. 2024 was 16.58%.

As of today, Alk-Abello A/S's current FCF Yield % is 1.31%.

The historical rank and industry rank for Alk-Abello A/S's FCF Margin % or its related term are showing as below:

STU:4AJ0' s FCF Margin % Range Over the Past 10 Years
Min: -22.47 Med: 1.83 Max: 9.08
Current: 9.08

During the past 13 years, the highest FCF Margin % of Alk-Abello A/S was 9.08%. The lowest was -22.47%. And the median was 1.83%.

STU:4AJ0's FCF Margin % is ranked better than
87.18% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs STU:4AJ0: 9.08

Alk-Abello A/S FCF Margin % Historical Data

The historical data trend for Alk-Abello A/S's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello A/S FCF Margin % Chart

Alk-Abello A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1.07

2.26

5.23

1.40

5.97

Alk-Abello A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															5.11	-9.96	9.01	17.69	16.58

Competitive Comparison of Alk-Abello A/S's FCF Margin %

For the Biotechnology subindustry, Alk-Abello A/S's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alk-Abello A/S's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello A/S's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alk-Abello A/S's FCF Margin % falls into.

Alk-Abello A/S FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alk-Abello A/S's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	38.64	/	647.218
	=	5.97 %

Alk-Abello A/S's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	30.041	/	181.189
	=	16.58 %

Alk-Abello A/S FCF Margin % Related Terms

Thank you for viewing the detailed overview of Alk-Abello A/S's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alk-Abello A/S (STU:4AJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello A/S (STU:4AJ0) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AKBLF:USA ALKBc:UK 0OIR:UK ALK B:Denmark 4AJ0:Germany

Address

Boge Alle 6-8, Horsholm, DNK, DK-2970

Website

https://www.alk.net

Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello A/S (STU:4AJ0) Headlines

No Headlines